Talnetant

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameTalnetant
Drug Alias Nametalnetant他奈坦他尔奈坦talnetantumSB-223412 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 3 receptor antagonists
TargetsNeurokinin 3 receptor
Therapy Area/IndicationsSchizophreniaIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[10] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsSchizophreniaIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG